Moving Together: An Online Group Movement Program for People Living With Memory Loss and Caregivers

November 1, 2023 updated by: University of California, San Francisco

Extending Independence and Quality of Life for People With Alzheimer's Disease or Dementia Through Telehealth Program Delivery

To determine whether Moving Together improves quality of life in people with memory loss (PWML) and caregivers (CG) by performing a randomized, controlled trial (RCT) with a waitlist control group in 224 dyads.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The investigators will perform an RCT with a 12-week delayed start control group in 224 dyads of PWMLs and CGs. The primary outcome in PWML will be self-rated quality of life (Quality of Life in Alzheimer's Disease, QOL-AD). Secondary outcomes will include: a) self-reported emotional well-being; b) self-reported social isolation; c) self-reported mobility; and d) directly assess cognitive performance. In CGs, the primary outcome will be self-rated quality of life (SF-12). Secondary outcomes in CGs will include: a) healthy days; b) self-efficacy; c) burden; d) social isolation; e) ability to self-regulate; f) positive affect; and g) sleep quality. In addition, the investigators will ask CGs to report sleep quality, mobility, and cognitive function for PWML. Additional exploratory outcomes will include health services utilization (hospitalizations, emergency department visits) and falls.

In addition to the RCT, the investigators propose to compare health utilization outcomes in study participants to a matched 'no contact' comparison sample of patients with dementia diagnoses who receive care in the University of California San Francisco (UCSF) Health system.

Study Type

Interventional

Enrollment (Actual)

197

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Francisco, California, United States, 94143
        • University of California, San Francisco

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • People with memory loss (PWML):

    • U.S. resident;
    • English language fluency;
    • diagnosis of Alzheimer's disease or other dementia; mild severity, assessed using the Quick Dementia Rating System.
  • Caregivers (CG):

    • U.S. resident;
    • English language fluency;
    • Primary caregiver for PWML;
    • own one or more devices that can be used to participate in two-way livestreaming video classes (e.g., smart phone/tablet + TV, laptop or desktop with webcam, smart TV);
    • willing and able to participate in two-way livestreaming group movement classes with person with PWML.

Exclusion Criteria:

  • Age < 18 years;
  • primarily use wheelchair inside home;
  • limited life expectancy (e.g., enrolled in hospice, meta-static cancer);
  • physical limitations that could affect ability to participate (e.g., difficulty sitting for 1 hour, chronic pain, vertigo);
  • severe visual impairment (e.g., unable to observe instructor's movements on screen);
  • severe hearing impairment (e.g., unable to hear instructor's requests);
  • behavioral or psychiatric issues that could be disruptive in group setting (e.g., history of physical or verbal abuse, schizophrenia, bipolar disorder, substance abuse);
  • unable to provide consent/assent;
  • planning to travel for >1 week during initial 12-week study period.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Immediate Start
The Immediate Start group will participate in the 12-week Moving Together program after completing the baseline assessment. Moving Together is a gentle, live-streaming, group movement program designed specifically for people with memory loss (PWML) and caregivers (CG) to do together. It is based on the in-person Preventing Loss of Independence through Exercise (PLIÉ) and Paired PLIÉ programs. The program combines physical movements to help maintain daily function with mindful body awareness exercises and social interactions to provide a comprehensive, multi-domain program.

Two-way livestreaming virtual group classes will be offered for 1 hour, 2 days/week for 12 weeks to all participants. Classes will be led by a trained instructor who will demonstrate all movements and will provide brief explanations for the goals of movements. Consistent with the in-person program, classes will focus on the 7 guiding principles of Moving Together:

  1. repetition with variation (to promote procedural learning);
  2. progressive, functional movements (to improve daily function);
  3. slow pace and step-by-step instruction (to minimize cognitive demands);
  4. participant-centered goal orientation (to enhance personal meaningfulness of movements);
  5. body awareness, mindfulness and breathing (to encourage present-centeredness);
  6. social interaction (to promote meaningful connection); and
  7. positive emotions (to promote feelings of well-being.
Other Names:
  • Together Senior Health
Experimental: Delayed Start
A Delayed Start group will be encouraged to continue with their usual daily activities during the first 12 weeks of the study and will begin the Moving Together program after completing the mid-point assessment.

Two-way livestreaming virtual group classes will be offered for 1 hour, 2 days/week for 12 weeks to all participants. Classes will be led by a trained instructor who will demonstrate all movements and will provide brief explanations for the goals of movements. Consistent with the in-person program, classes will focus on the 7 guiding principles of Moving Together:

  1. repetition with variation (to promote procedural learning);
  2. progressive, functional movements (to improve daily function);
  3. slow pace and step-by-step instruction (to minimize cognitive demands);
  4. participant-centered goal orientation (to enhance personal meaningfulness of movements);
  5. body awareness, mindfulness and breathing (to encourage present-centeredness);
  6. social interaction (to promote meaningful connection); and
  7. positive emotions (to promote feelings of well-being.
Other Names:
  • Together Senior Health

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life - change (Quality of Life in Alzheimer's Disease Scale, QOL-AD)
Time Frame: Baseline to 12-weeks
The QOL-AD is a standard quality of life measure that has been validated for people with cognitive impairment. Scores may range from 0-52, with higher scores reflecting better quality of life.
Baseline to 12-weeks
Caregiver Health - change (Short Form Health Survey (SF-12))
Time Frame: Baseline to 12-weeks
The Short Form Health Survey (SF-12) is a 12-item questionnaire that was developed as a shorter alternative to the SF-36 Health Survey (SF-36). It consists of a subset of 12 items from the SF-36 covering the same eight domains of health outcomes and generates two summary scores: the Physical and Mental Health Composite Scores (PCS, MCS). Scores may range from 0-100, with higher scores reflecting better levels of health.
Baseline to 12-weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Well-being - change (Neuro-QOL v1.0 Positive Affect and Well-Being Short Form)
Time Frame: Baseline to 12-weeks
The Neuro-QOL v1.0 Positive Affect and Well-Being Short Form includes 9 items (e.g. sense of well-being, feeling hopeful, life was satisfying, etc.) with 5-point responses from never (1) to always (5). Scores range from 0-40 with higher scores indicating increased mobility.
Baseline to 12-weeks
Social isolation - change (Patient-Reported Outcomes Measurement Information System v2.0 social isolation scale)
Time Frame: Baseline to 12-weeks
The Patient-Reported Outcomes Measurement Information System v2.0 social isolation scale consists of 4 items (feeling left out, people barely know me, feeling isolated, people are around but not with me) that are rated as 1 (never), 2 (rarely), 3 (sometimes), 4 (usually), or 5 (always). Scores range from 0-20 with higher scores indicating less perceived social isolation.
Baseline to 12-weeks
Mobility - change (Neuro-QOL Short Form V1.0 - Lower Extremity Function - Mobility)
Time Frame: Baseline to 12-weeks
The (Neuro-QOL Short Form v1.0 -- Lower Extremity Function -- Mobility), which includes 8 items for functional mobility (getting on and off the toilet, getting in and out of a car, getting out of bed into a chair). Responses are rated on a 5-point Likert scale: 1( Without any difficult), 2 (With a little difficulty), 3 (With some difficulty), 4 (With much difficulty), 5 (Unable to do). Scores may range from 0-40 with higher scores indicating increased mobility.
Baseline to 12-weeks
Cognitive function - change (telephone Montreal Cognitive Assessment, t-MoCA)
Time Frame: Baseline to 12-weeks
The t-MoCA is extracted from the original face-to-face MoCA and uses items not requiring the use of a pencil and paper or visual stimulus. Scores may range from 0-22 with higher scores indicating higher cognitive function.
Baseline to 12-weeks
Caregiver Healthy Days - change (Healthy Days Core Module)
Time Frame: Baseline to 12-weeks
The Healthy Days Core Modules includes 3 questions about the number of days during the past 30 days that physical or mental health was not good or poor physical or mental health kept from doing usual activities. Scores range from 0-18 with lower scores indicating higher physical or mental health.
Baseline to 12-weeks
Caregiver self-efficacy - change (Gain in Alzheimer care INstrument (GAIN))
Time Frame: Baseline to 12-weeks
The GAIN consists of 10-items (e.g., increased my self-awareness, increased my knowledge and skills in dementia care) using a Likert scale from 0 (disagree a lot) to 4 (agree a lot). Scores range from 0 to 40 with higher scores indicating increased positive feelings about caregiving
Baseline to 12-weeks
Caregiver burden - change (Zarit Burden Interview, 6-item version)
Time Frame: Baseline to 12-weeks
The Zarit Burden Interview is one of the most widely used assessments for caregiver burden covering areas including caregiver's health, psychological well-being, finances, social life, and the relationship between the caregiver and the person with dementia. Scores range from 0-24 with higher scores indicating positive caregiver experience.
Baseline to 12-weeks
Caregiver social isolation - change (PROMIS v2.0 social isolation scale)
Time Frame: Baseline to 12-weeks
The Patient-Reported Outcomes Measurement Information System v2.0 social isolation scale consists of 4 items (feeling left out, people barely know me, feeling isolated, people are around but not with me) that are rated as 1 (never), 2 (rarely), 3 (sometimes), 4 (usually), or 5 (always). Scores range from 0-20 with higher scores indicating less perceived social isolation.
Baseline to 12-weeks
Caregiver self-regulation - change (Abbreviated Multidimensional Assessment of Interoceptive Awareness-2 (MAIA) self-regulation subscale)
Time Frame: Change from baseline to 12-weeks
The MAIA-2 - Self-regulation subscale is designed to assess ability to regulate distress by attention to body sensations (e.g., when I feel overwhelmed, I can find a calm place inside). Scores range from 0-20 with higher scores indicating increased self-regulation.
Change from baseline to 12-weeks
Caregiver positive affect (Positive States of Mind)
Time Frame: Baseline to 12-weeks
The Positive States of Mind scale is designed to assess types of positive mood (e.g., focused attention, productivity, responsible caregiving, etc.). This scale consists of 6-items using a 4-point Likert scale from 0 (Unable to have it) to 3 (Have it Easily). Scores range from 0-18 with higher scores indicating positive mood.
Baseline to 12-weeks
Caregiver sleep - change (Symptom Checklist, 3 items)
Time Frame: Baseline to 12-weeks
The Symptom Checklist-90-Revised is a 90-item self-report questionnaire often used to assess global psychological distress and the investigators will be using 3 items assessing: trouble falling asleep, awakening in the early morning, and sleep that is restless or disturbed. Scores range from 0-12 with lower scores indicating less sleep difficulties.
Baseline to 12-weeks
People With Memory Loss (PWML) sleep - change (Symptom Checklist, 3 items)
Time Frame: Baseline to 12-weeks
Caregivers also will be asked about sleep for the PWML using the 3 sleep items from the Symptom Checklist-90-Revised (trouble falling asleep, awakening in the early morning, and sleep that is restless or disturbed). Scores range from 0-12 with lower scores indicating less sleep difficulties.
Baseline to 12-weeks
People With Memory Loss (PWML) mobility - change (Neuro-QOL Short Form V1.0 - Lower Extremity Function - Mobility)
Time Frame: Baseline to 12-weeks
As described above, the Neuro-QOL Short Form v1.0 - Lower Extremity Function - Mobility includes 8 items for functional mobility (e.g. getting on and off the toilet, getting in and out of a car, getting out of bed into a chair, etc.). CGs will be asked about the mobility of the PWML. Scores range from 0-35 with higher scores indicating less physical difficulty with daily activities.
Baseline to 12-weeks
People With Memory Loss (PWML) cognitive function - change (Cognitive Function Instrument - Modified)
Time Frame: Baseline to 12-weeks
The original Cognitive Function Instrument included 14 items that asked about decline in cognitive function (e.g., memory, tendency to repeat questions, misplacing things, etc.) compared to 1 year ago with responses of yes (1), no (0) or maybe (0.5). The investigators will be using a modified 11-item version that excludes items on driving, managing money, work; asking about change in the past 3 months (to match the duration of our study); and using a 5-point Likert scale from 1 (a lot worse) to 5 (a lot better). Scores range from 0-55 with higher scores indicating improved cognitive function.
Baseline to 12-weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Preventing Loss of Independence through Éxercise (PLIÉ) Experience Scale
Time Frame: 12 weeks in the immediate start group. 24 weeks in the delayed start group.
The PLIÉ Experience Scale is designed to capture feelings of stigma as well as elements of the program that participants have self-reported change. Six items including (belonging, acceptance, problems are not unique, energy, relaxation, enjoying being with similar people are rated on a 4-point Likert scale. Scores range from 0-24 with higher scores indicating positive feelings about the PLIÉ program.
12 weeks in the immediate start group. 24 weeks in the delayed start group.
Final Evaluation Survey
Time Frame: 12 weeks in the immediate start group. 24 weeks in the delayed start group.
After completing the final class, participants will be asked to provide an overall rating of the program (poor, fair, good, or excellent), to indicate whether they would recommend it to others on a 11-point Likert scale (0, not at all likely to 10, highly likely), as well as open-ended questions that will ask about qualitative changes observed in themselves, their study partners, and others in the class; what they liked most, and suggestions for improvement.
12 weeks in the immediate start group. 24 weeks in the delayed start group.
Health Services Utilization
Time Frame: 24 weeks
Emergency department/urgent care visits, hospitalizations (Number/month)
24 weeks
Caregiver (CG) Falls
Time Frame: 24 weeks
Number of falls for CG
24 weeks
People with Memory Loss (PWML) Falls
Time Frame: 24 weeks
Number of falls for PWML
24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Deborah Barnes, PhD, MPH, University of California, San Francisco

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 18, 2020

Primary Completion (Actual)

May 3, 2023

Study Completion (Actual)

May 12, 2023

Study Registration Dates

First Submitted

November 3, 2020

First Submitted That Met QC Criteria

November 3, 2020

First Posted (Actual)

November 9, 2020

Study Record Updates

Last Update Posted (Actual)

November 7, 2023

Last Update Submitted That Met QC Criteria

November 1, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Sharing permissions will be configured to ensure files containing PHI can only be accessed by authorized individuals. Two-step verification will be used as an additional safeguard against unauthorized access. Permissions will be updated when personnel roles change and they no longer need access to PHI or when they leave the research team.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on Moving Together

3
Subscribe